Empower patients with MS-Selfie, a resource by MS expert Prof. Gavin Giovannoni, offering guidance on treatment, switching decisions, and informed care management.
Upcoming 2024 revisions to the McDonald criteria will integrate new MRI technologies and biomarkers, such as neurofilament light chain and the central vein sign, to enable earlier and more accurate MS diagnoses, including in individuals previously classified as having radiologically isolated syndrome.
Explore new findings reporting how vaccinations do not increase the risk of MS in children and adolescents and how urinary tract infections are the leading cause of hospital admissions for people with MS, underscoring the need for improved bladder care and outpatient management strategies.
Explore the latest research insights for MS nurses, covering key advancements in MS management. Highlights include the potential of high-dose vitamin D to delay early MS progression, the impact of disease-modifying treatments on slowing disability in RRMS, and findings from the MS-STAT2 trial on simvastatin’s limitations in SPMS. Stay informed with these evidence-based updates to enhance patient care.
Multiple sclerosis (MS) can significantly impact sexual health, with 40-80% of women and 50-90% of men with MS reporting sexual concerns. Challenges may arise from direct neurological effects, disease symptoms, or psychological and social factors.
Significant progress has advanced our understanding of NMOSD and MOGAD. This 30-minute microlearning covering key features, diagnostic criteria, and emerging therapies, enabling better differentiation from MS will be launch in January 2025.
Hematopoietic stem cell transplantation (HSCT), Bruton's tyrosine kinase (BTK) inhibitors and chimeric antigen receptor (CAR) T-cell therapies are three potential future MS therapies currently under investigation. Read more about latest developments in this blogpost.
It is important for MS Nurses to have a good understanding of generics and biosimilars, including what they are and how they are approved by regulatory agencies, and to have confidence in discussing these with PwMS as they are likely to become an increasing part of clinical practice moving forward.
Course 1 on Understanding MS and Course 2 on the Clinical Presentation of MS have been renewed!
Enroll to our Foundation Programme on MS Nursing available in the Catalogue to check it out!
ChatGPT vs. neurologist: what do patient prefer? High efficacy treatment in paediatric-onset MS to significantly reduce disability progression. Updated guidance on cladribine for aggressive RRMS. PwMS with cognitive impairment tend to report a worse quality of life compared to PwMS without it.
The European Commission has approved a subcutaneous formulation of ocrelizumab to treat adults with MS and it is now available to people with relapsing forms of multiple sclerosis as well as primary progressive multiple sclerosis.
Nurse burnout, prevalent in up to 68% of nurses, not only affects the well-being of nurses but also has significant negative impacts on patients and healthcare organizations. Read how to recognise the signs and how to avoid burning-out.
Get up-to-date on 'How misinformation affects family planning choices of women with MS'; 'Pregnancy clinics and the role of the MS Specialist Nurse' and Transitioning of MS care from adolescence to adulthoud.
Read this article to gain insights into reliable digital information sources for neuroscience nurses and individuals with MS, along with tips on navigating these sources. Learn digital skills to better support your people with MS.
Unlock your MS health potential! A balanced diet empowers symptom control, emphasizing vital nutrients for resilience and well-being. Find out how you and your patients can improve through diet.
